On October 10, 2019－11, HOPE medicine held in nanchang city in jiangxi province participated in the 23rd China international exhibition on medicine (industrial) and technology communication meeting and the 83th session of China international pharmaceutical apis, intermediates, packaging, equipment fair, give the industry a professional communication with participation of highly integrated industry event.

In this exhibition, HOPE medicine with advanced technology, quality products and services, so that many peer merchants stop to discuss. For the technical problems of customer consultation and our superior products, the sales staff made in_depth exchanges and communication with the customer, and our r & d strength and technical ability were unanimously recognized by the customer, and reached the intention of cooperation.

API participation process, the company research and development director Dr Zhang xu, in "the second session of MAH development of new opportunities and challenges _ API China BBS & industrial innovation model will discuss" made in the research and development of chemical medicine preparations registration API choice in the process of professional report, report Dr. Zhang generalizes the national policy of calendar year, and from the perspective of customers and API supplier preparation respectively expounds the respective focus on the key factors, and enumerates the interaction between the various ways, for many people in the industry in the process of research and development of chemical medicine preparations registration API selection provides a new train of thought.

HOPE medicine has always been adhering to the "integrity, professionalism, cooperation, win_win" enterprise core values, with rigorous and efficient research and development capabilities and innovative technology, and strive to make the technology and products perfect, in order to repay customers, repay the society!

【Introduction to HOPE medicine】

Established in April 2005 (stock code: 836438), Beijing HOPE pharmaceutical technology co., ltd. is a high_tech enterprise engaged in the research and development, production and sales of chemical drugs. The company's main business covers pharmaceutical and clinical CRO services, research and development, associated registration and customized production of high_end API and pharmaceutical intermediates, as well as research and development of chemical pharmaceutical preparations and MAH business. Research and development of products involving anti_tumor, anti_depression, cardiovascular and cerebrovascular, digestive system, respiratory system and other areas.

In China, more than 60 drug clinical trial approvals, more than 10 new drug certificates and drug registration approvals have been obtained, and more than 10 series of high_end API and intermediate products have been commercialized and promoted and sold globally.

The company is committed to the optimization and innovation of chemical drug synthesis process, and has achieved a series of excellent results in the application of innovative technologies such as efficient asymmetric catalysis, enzyme catalysis and continuous flow reaction technology, challenging crystal and process technology patents, small molecule structure transformation, etc. Now, it has applied for more than 10 related invention patents and authorized 10.

【cooperation information】

Business cooperation:

Contact: Chen zhutuo tel: 18010182349 email: chenzhutuo@hopelife.cn

API cooperation:

Contact person: Yu fuqiang  tel: 15010704183  email: yufuqiang@hopelife.cn